Dapagliflozin (Farxiga)

Endocrinology / Cardiology (SGLT2 Inhibitor)

Dosing & Administration

Adult Dose

10 mg PO daily.

Pediatric Dose

Not established.

Renal Adjustment

eGFR < 25: Do not initiate.

Hepatic Adjustment

Start at 5 mg daily in severe impairment.

Safety & Special Populations

Pregnancy Category

Avoid in 2nd/3rd trimester.

Lactation Safety

Not recommended.

Contraindications & Adverse Effects

Contraindications

  • Dialysis

Common Adverse Effects

  • Genital mycotic infections
  • UTIs
  • Euglycemic DKA